International Randomized Trial on the Effect of Revascularization or Optimal Medical Therapy of Chro
The ISCHEMIA-CTO trial
TRIAL ARTICLE
International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design
TRIAL REGISTRATION
Clinical Trials
NCT03563417
ISCHEMIA-CTO
To investigate PCI vs. optimal medical therapy of CTO lesions in patients with significant myocardial ischemia and PCI vs. optimal medical therapy of CTO lesions in patients with moderate myocardial ischemia
Trial period
•
2018 - 2028
Status
•
Including
Inclusions
•
1560 Ongoing
Centers
•
15
Countries
•
6
Publications
•
1
MEDIA
PUBLICATIONS
International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design
Råmunddal Truls, Holck Emil Nielsen, Karim Salma, Eftekhari Ashkan, Escaned Javier, +14 more